The following presentation has today been submitted to the National Storage Mechanism and will shortly be available for inspection at ...

What will be included in next week's quarterly update? The post Own ANZ shares? Here's what to watch in next week's report ...

In the Phase 2 open-label Oral Anaphylm Symptom Intervention Study ("OASIS”) study, adults with Oral Allergy Syndrome (n=36) received Anaphylm under different conditions, including single and repeat ...

Gilat's Management will discuss its fourth quarter and full year 2024 results and business achievements and participate in a question-and-answer session: 09:30 AM EST / 16:30 IST ...

Revenue of $78.1 million, GAAP Operating Income of $12.8 million and Adjusted EBITDA of $12.1 million 2024 Revenue of $305.4 million, GAAP Operating Income of $27.7 million and a 25-year Record Adjust ...

This is further to our letters dated 31st January 2025 wherein we had given an advance intimation of the Analyst / Institutional Investor Meeting in terms of Regulation 30(6) read with Para A (15) (a) ...

Cattella Group reported a strong fourth quarter for 2024, with net revenue increasing by 39% year-on-year to SEK 2.3 billion. Despite restructuring costs impacting earnings before interest and taxes ...

Global system-wide sales grow 5.6% for the fourth quarter and 5.4% for 2024Global comparable sales up 2.5% in Q4, led by 4.7% at INTL and 2.5% at TH Canada2024 Income ...

Tenet Healthcare recorded lower revenue but stronger earnings in the fourth quarter after it divested 14 hospitals last year. The operator of hospitals and surgery centers posted a profit of $318 ...